FDA Reports Hearing Loss Linked To Viagra And Other PDE5 Inhibitors

The US Food and Drug Administration (FDA) has received reports of sudden reduction or loss of hearing following the use of PDE5 inhibitors, a class of drugs that includes the erectile dysfunction (ED) medications Viagra, Levitra, and Cialis and also Revatio, used to treat pulmonary arterial hypertension (PAH). [click link for full article]

More: continued here

Filed under: Erectile Dysfunction / Premature Ejaculation on October 25th, 2007